Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
Vertex Pharmaceuticals Inc (VRTX) has a market cap of $113.01B with year-over-year revenue growth of +8.9%. Net margin stands at 32.9%. The stock trades at a P/E ratio of 28.6.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, VRTX posted revenue growth of +8.9% and trades at a P/E of 28.6.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.